Latest News

Oncolytic Viruses Put Immune System on High Alert
Combining oncolytic viruses and immunotherapies may fight cancer more effectively.
Treatment with durvalumab (Imfinzi) reduces the risk of disease progression among patients with non-small cell lung cancer.
Enzalutamide (Xtandi) demonstrates a significant reduction in metastasis or death from castration-resistant prostate cancer
Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks to the difficulties that face manufacturers who are launching a novel specialty product.
PRDM14 is involved with embryonic development and may lead to germ cell tumors.
Top news of the day from across the health care landscape.
Many key specialty pharmacy issues discussed at the Payer/Managed Care Strategies for Specialty Medications Annual Symposium.
Health care professionals should provide resources that help patients with HIV practice self-care.

Features

Generics in Specialty: “The Future Ain’t What It Used to Be”
The widespread acceptance of generics in the specialty channel is a high-stakes matter, as providers that encourage rapid adoption of new specialty generics are poised to wield a distinct competitive advantage.
In 2018, watch for novel cancer drugs and several new orphan drugs to affect the market.
Strategies for approaching the numerous developing trends in the specialty pharmacy market are vital to a successful plan of action in 2018.
Specialty pharmaceuticals featured prominently in the actions of the FDA in 2017.

Featured Company Profile

 
MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy

Videos

Joy Gilbert, Vice President, Operations, US Bioservices, a part of AmerisourceBergen, speaks to the difficulties that face manufacturers who are launching a novel specialty product.

A look at the top stories in the world of pharmacy from last week.

Christopher W. Kennedy, MSM, Chief Operating Officer, Heritage Biologics, discusses the importance of value-based care for the specialty pharmacy industry.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses the features specialty pharmaceutical manufacturers look for when choosing a data aggregator.

Current Issue

January/February
Volume: 9
Number: 1

Most Popular

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$